Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
196.96
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
203
Open
196.96
Bid (Size)
196.10 (1)
Ask (Size)
197.50 (1)
Prev. Close
196.96
Today's Range
196.96 - 196.96
52wk Range
135.85 - 199.95
Shares Outstanding
N/A
Dividend Yield
3.01%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition
October 01, 2024
Via
Investor Brand Network
Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition
October 01, 2024
EQNX::TICKER_START (NYSE:ANVS),(NYSE:LLY),(NYSE:PFE),(NYSE:NVO),(NASDAQ:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Performance
YTD
+23.24%
+23.24%
1 Month
-0.37%
-0.37%
3 Month
+18.68%
+18.68%
6 Month
+9.00%
+9.00%
1 Year
+32.86%
+32.86%
More News
Read More
Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
September 30, 2024
Via
Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
September 27, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
September 26, 2024
Via
Benzinga
15 Best Dividend Stocks for Lifelong Passive Income
September 30, 2024
Via
The Motley Fool
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Via
Benzinga
Exposures
Product Safety
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
September 26, 2024
Via
Benzinga
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
September 26, 2024
Via
The Motley Fool
Behind the Scenes of AbbVie's Latest Options Trends
September 24, 2024
Via
Benzinga
Spotlight on AbbVie: Analyzing the Surge in Options Activity
September 20, 2024
Via
Benzinga
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
September 19, 2024
Via
Benzinga
Is ABBVIE INC Ready to Break Out of Its Range?
September 17, 2024
Via
Chartmill
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
Via
Benzinga
Exposures
Product Safety
2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure?
September 19, 2024
Via
Investor's Business Daily
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
September 19, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Abbie Inc Stocks Elliott Wave Technical Analysis - Wednesday, September 18,
September 18, 2024
Via
Talk Markets
TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades'
September 17, 2024
Via
Benzinga
Topics
ETFs
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
September 16, 2024
Via
The Motley Fool
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
September 14, 2024
Via
The Motley Fool
3 Stocks to Buy and Hold Forever
September 14, 2024
Via
The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
September 14, 2024
Via
The Motley Fool
Time To Invest And Or Trade In Bio-Tech Stocks?
September 13, 2024
Via
Talk Markets
Topics
ETFs
Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
September 13, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
September 11, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.